BIO Earnings

Quarterly EPS
$23.37
Q3 2024
$-25.57
Q4 2024
$2.29
Q1 2025
$11.67
Q2 2025
$-12.70
Q3 2025
$26.70
Q4 2025
$-19.55
Q1 2026
$13.89
Q2 2026
Latest Revenue651.0M
Latest Net Income371.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$13.89651.0M371.4M-0.1%+19.0%
Q1 2026-$19.55592.1M-527100000+1.1%-953.7%
Q4 2025$26.70693.2M720.0M+3.9%+204.4%
Q3 2025-$12.70653.0M-341900000+0.5%-154.3%
Q2 2025$11.67651.6M317.8M+2.1%+115.3%
Q1 2025$2.29585.4M64.0M-4.2%-83.0%
Q4 2024-$25.57667.5M-715800000-2.0%-310.5%
Q3 2024$23.37649.7M653.2M+2.8%+540.3%
Q2 2024-$76.26638.5M-2165500000
Q1 2024$13.46610.8M383.9M
Q4 2023$12.15681.1M349.7M
Q3 2023$3.65632.1M106.3M
Bio-Rad Laboratories, Inc.Class A (BIO) — Earnings